Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOKYO.L Regulatory News (OKYO)

  • There is currently no data for OKYO

Board Changes

11 Oct 2012 09:26

RNS Number : 4727O
West African Minerals Corporation
11 October 2012
 



 

For immediate release

12 October 2012

West African Minerals Corporation

("WAFM" or the "Company")

Board Changes

 

West African Minerals Corporation announces that Mr. Guy Elliott has informed the Board that due to other commitments, he will cease to be a non-executive Director of the Company with immediate effect.

The Board wishes to thank Mr. Elliott for his contribution and wishes him every success for the future.

 

For further information:

 

West African Minerals Corporation

Denham Eke

Chief Financial Officer

 

Donna Yoshimatsu

Investor Relations and Corporate Secretary

 

+44 (0) 1624 639396

 

 

+1 (416) 722-2456

Beaumont Cornish Limited (Nominated Adviser)

Roland Cornish

Michael Cornish

 

+44 (0)20 7628 3396

Investec Bank PLC (Broker)

Neil Elliot

 

+44 (0)20 7597 5970

GTH Communications

Toby Hall

Suzanne Johnson Walsh

+44 (0) 20 3103 3902

 

About West African Minerals Corporation

 

West African Minerals Corporation (AIM: WAFM) is an iron ore mining and exploration group focused on West Africa with interests in iron ore exploration licences in Cameroon and Sierra Leone. Further information on the Group is available at www.westafricanminerals.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFFISAFFESEES
Date   Source Headline
19th Mar 20207:00 amRNSPlacing to raise £560,000
2nd Mar 202011:50 amRNSResult of AGM
19th Dec 20197:00 amRNSDirectorate Change
29th Nov 20197:00 amRNSHalf-year Report
28th Aug 20197:00 amRNSChemerin Update
19th Aug 20197:00 amRNSCollaboration with Prof. Pedram Hamrah
30th Jul 20192:05 pmRNSSecond Price Monitoring Extn
30th Jul 20192:00 pmRNSPrice Monitoring Extension
1st Jul 20197:00 amRNSFinal Results
30th May 20192:52 pmRNSHolding(s) in Company
20th May 201910:58 amRNSResult of General Meeting
26th Apr 20197:00 amRNSSubscription and Waiver
25th Apr 20195:30 pmRNSHolding(s) in Company
7th Mar 20197:00 amRNSPresentation of Preclinical Data
23rd Jan 20197:00 amRNSCorporate Update
30th Nov 20184:06 pmRNSHalf-year Report
1st Nov 20187:00 amRNSExpected Admission Date for Consideration Shares
24th Oct 20187:00 amRNSAllotment of Ordinary Shares & Listing Application
21st Sep 20187:00 amRNSAppointment of Senior R&D Director
6th Sep 201812:38 pmRNSResult of AGM
22nd Aug 201812:13 pmRNSHolding(s) in Company
21st Aug 201812:09 pmRNSAnnual Report and Notice of AGM
31st Jul 20186:05 pmRNSFinal Results
9th Mar 201811:01 amRNSResult of General Meeting and Corporate Update
2nd Mar 201812:47 pmRNSChange of Broker
21st Feb 20185:00 pmRNSSuspension - Okyo Pharma Corporation
21st Feb 20185:00 pmRNSProposed cancellation, suspension, notice of GM
2nd Feb 20181:17 pmRNSChange of Name and Corporate Update
10th Jan 201811:14 amRNSResult of General Meeting
4th Jan 20189:52 amRNSIssue of Equity, Directors' Dealing
21st Dec 201710:40 amRNSProposed Disposal, Special Dividend, Notice of GM
18th Dec 201712:23 pmRNSInterim Report for Period Ended 30 September 2017
13th Nov 20174:12 pmRNSBoard Changes and Corporate Update
29th Sep 20177:00 amRNSReport and Accounts for year to 31 March 2017
6th Jul 20171:47 pmRNSBoard Appointment
16th Jun 20171:18 pmRNSHolding(s) in Company
8th Jun 20175:07 pmRNSHolding(s) in Company
5th Jun 20177:00 amRNSDirectorate Change
12th May 20177:00 amRNSScoping Study
22nd Dec 201612:34 pmRNSHalf-year Report
29th Sep 20165:50 pmRNSAnnual Financial Report
12th Aug 20167:00 amRNSChange of Broker
1st Apr 201612:44 pmRNSBoard Changes and Corporate Update
11th Feb 20167:00 amRNSDirector's Dealing
22nd Dec 20157:00 amRNSHalf Yearly Report
29th Sep 20153:45 pmRNSAnnual Financial Report
21st Aug 20154:37 pmRNSCorporate Update
27th Jul 20157:00 amRNSDirectors' dealing
2nd Jun 20157:00 amRNSBoard changes and withdrawal of requisition
29th Apr 201512:15 pmRNSRequisition of General Meeting - Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.